Literature DB >> 20548034

Direct comparison of Dll1- and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes.

Mahmood Mohtashami1, Divya K Shah, Hiroshi Nakase, Korosh Kianizad, Howard T Petrie, Juan Carlos Zúñiga-Pflücker.   

Abstract

In the thymus, Notch signaling is essential for T lymphopoiesis, with Delta-like (Dll)4 uniquely involved in this process. However, using cocultures, either Dll4 or Dll1 were shown to support T lymphopoiesis. To address which Dll is more effective at inducing hematopoietic progenitor cells to give rise to T lineage cells in vitro, we generated OP9 cells expressing a series of incrementally discrete and equivalent levels of Dll1 or Dll4. In keeping with previous findings, OP9 cells expressing high levels of either Dll1 or Dll4 gave rise to T lineage cells with similar efficacy, and prevented the differentiation of B and myeloid-lineage cells. However, at limiting levels, Dll4 maintained its ability to inhibit B lineage choice and induce T lineage commitment and differentiation at lower levels than Dll1. This manifest property of Dll4 is evident despite lower levels of steady-state surface expression than Dll1 on OP9 cells. The heightened effectiveness of Dll4 over Dll1 also corresponded to the induction of Notch target genes, and inhibition of B and myeloid-specific transcription factors. Furthermore, we show that OP9 cells expressing levels of Dll4 equivalent to those present in thymic epithelial cells, as expected, gave rise to T lineage cells, but were also permissive for the differentiation of myeloid cells; whereas, still inhibiting B lymphopoiesis. Our findings show that Dll4 expressed at physiological levels on OP9 cells is functionally distinct from similarly expressed levels of Dll1, illustrating the unique properties of Dll4 in supporting the combined T lineage and specific myeloid-lineage outcomes that underpin its function within the thymus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20548034     DOI: 10.4049/jimmunol.1000782

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes.

Authors:  Gladys W Wong; Gisele C Knowles; Tak W Mak; Adolfo A Ferrando; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

2.  Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies.

Authors:  Itai M Pessach; Jose Ordovas-Montanes; Shen-Ying Zhang; Jean-Laurent Casanova; Silvia Giliani; Andrew R Gennery; Waleed Al-Herz; Philip D Manos; Thorsten M Schlaeger; In-Hyun Park; Francesca Rucci; Suneet Agarwal; Gustavo Mostoslavsky; George Q Daley; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2010-12-24       Impact factor: 10.793

Review 3.  Cytokines, Transcription Factors, and the Initiation of T-Cell Development.

Authors:  Hiroyuki Hosokawa; Ellen V Rothenberg
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

4.  Pre-T Cell Receptors (Pre-TCRs) Leverage Vβ Complementarity Determining Regions (CDRs) and Hydrophobic Patch in Mechanosensing Thymic Self-ligands.

Authors:  Dibyendu Kumar Das; Robert J Mallis; Jonathan S Duke-Cohan; Rebecca E Hussey; Paul W Tetteh; Mark Hilton; Gerhard Wagner; Matthew J Lang; Ellis L Reinherz
Journal:  J Biol Chem       Date:  2016-10-05       Impact factor: 5.157

Review 5.  Thymus machinery for T-cell selection.

Authors:  Kenta Kondo; Izumi Ohigashi; Yousuke Takahama
Journal:  Int Immunol       Date:  2019-03-05       Impact factor: 4.823

6.  GATA-3 locks the door to the B-cell option.

Authors:  Ellen V Rothenberg
Journal:  Blood       Date:  2013-03-07       Impact factor: 22.113

Review 7.  Regulation of innate and adaptive immunity by Notch.

Authors:  Freddy Radtke; H Robson MacDonald; Fabienne Tacchini-Cottier
Journal:  Nat Rev Immunol       Date:  2013-05-13       Impact factor: 53.106

8.  GATA-3 dose-dependent checkpoints in early T cell commitment.

Authors:  Deirdre D Scripture-Adams; Sagar S Damle; Long Li; Koorosh J Elihu; Shuyang Qin; Alexandra M Arias; Robert R Butler; Ameya Champhekar; Jingli A Zhang; Ellen V Rothenberg
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

Review 9.  Transcriptional control of early T and B cell developmental choices.

Authors:  Ellen V Rothenberg
Journal:  Annu Rev Immunol       Date:  2014-01-22       Impact factor: 28.527

Review 10.  Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.

Authors:  Arnab Ghosh; Amanda M Holland; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.